TopFunds

Edwards Lifesciences

NYSE: EW

Stock price

88.26 USD

(-26.09%) 5 years

Health Care EquipmentMedical - Devices

Insider Transactions

5Y price score: (35)
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: -26.09%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
11-sep.-26Sale(619)87.5(54,169)40,034Lippis Daniel J.officer: CVP, TAVRlink
31-aug.-26Sale(544)91.1(49,534)14,868Dahl Andrew M.officer: SVP, Corporate Controllerlink
28-aug.-26Sale(2,644)90.0(237,907)17,984Bruls Annetteofficer: CVP, EMEACLAlink
26-aug.-26Sale(1,154)91.8(105,893)74,970Chopra Daveenofficer: CVP, TMTT, Surgical & IHFMlink
26-aug.-26Sale(30,646)91.0(2,788,547)44,324Chopra Daveenofficer: CVP, TMTT, Surgical & IHFMlink
26-aug.-26Sale(1,240)91.5(113,417)20,294Markowitz Wayneofficer: CVP, JAPAClink
11-aug.-26Sale(619)92.0(56,967)40,034Lippis Daniel J.officer: CVP, TAVRlink
30-jul.-26Sale(146)86.0(12,588)21,534Markowitz Wayneofficer: CVP, JAPAClink
28-jul.-26Sale(9,628)85.1(818,958)21,680Markowitz Wayneofficer: CVP, JAPAClink
27-jul.-26Sale(2,921)83.9(245,134)8,916Zovighian Bernard Jdirector, officer: CEOlink

72.3

52-week range

96.2

88.26

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

2.8 %

Dividend Yield TTM

-

Market cap $

$ 50,820

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

50.7

Price / Book TTM

4.8

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

(0.7)

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

18.4 %

(26.1) %

127.1 %

Free cash flow per share growth

147.2 %

122.6 %

239.8 %

Earnings per share growth

(25) %

40.8 %

144 %

Analyst ratings

Price Target Low

85

Price Target High

110

Price Target Median

101

Buy

33

Hold

16

Sell

0

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
0.8
0.9
1
1.1
1.6
1.3
2.4
2.4
2.3
7
1.8
9.3%
3.1
3.4
3.8
4.2
4.7
4.9
02FCF per share
0.7
0.7
1.3
1.1
1.4
1
2.2
1.5
1
0.5
2.3
13%
2.2
2.5
2.7
3
3.3
3.4
03Dividends per share
Help
Adjusted for splitsLearn more
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
05Revenue
$ 2,494
$ 2,964
$ 3,435
$ 3,723
$ 4,348
$ 4,386
$ 5,233
$ 5,382
$ 5,010
$ 5,440
$ 6,068
9.3%
$ 6,632
$ 7,249
$ 7,923
$ 8,659
$ 9,465
$ 9,749
06ㅤ% Change
-
18.9%
15.9%
8.4%
16.8%
0.9%
19.3%
2.9%
(6.9)%
8.6%
11.6%
9.3%
9.3%
9.3%
9.3%
9.3%
9.3%
9.3%
07Net Income
494.9
569.5
622.1
722.2
1,047
823.4
1,503
1,522
1,402
4,175
1,074
8.1%
1,802
1,969
2,152
2,353
2,571
2,649
08ㅤ% Margin
19.9%
19.2%
18.1%
19.4%
24.1%
18.8%
28.7%
28.3%
28%
76.8%
17.7%
27.2% A
27.2%
27.2%
27.2%
27.2%
27.2%
27.2%
09CFO
549.7
704.4
1,001
926.8
1,179
1,054
1,732
1,218
895.8
542.3
1,595
11.2%
1,573
1,719
1,879
2,054
2,245
2,312
10ㅤ% Of revenue
22%
23.8%
29.1%
24.9%
27.1%
24%
33.1%
22.6%
17.9%
10%
26.3%
23.7% A
23.7%
23.7%
23.7%
23.7%
23.7%
23.7%
11CAPEX
(106.5)
(217.4)
(175.5)
(241.7)
(278.4)
(407.3)
(329.8)
(264.8)
(266.3)
(252.4)
(260.2)
9.3%
(284.5)
(311.1)
(340.2)
(372)
(406.7)
(444.7)
12ㅤ% Change
-
104.1%
(19.3)%
37.7%
15.2%
46.3%
(19)%
(19.7)%
0.6%
(5.2)%
3.1%
9.3% A
9.3%
9.3%
9.3%
9.3%
9.3%
9.3%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
443.2
487
825.2
685.1
901
647
1,402
953.4
629.5
289.9
1,335
11.7%
1,288
1,408
1,539
1,682
1,838
1,867
14Total assets
4,059
4,510
5,697
5,324
6,488
7,237
8,503
8,293
9,363
13,055
13,697
12.9%
15,469
17,469
19,728
22,279
25,161
28,415
15ㅤ% Change
-
11.1%
26.3%
(6.5)%
21.9%
11.5%
17.5%
(2.5)%
12.9%
39.4%
4.9%
12.9%
12.9%
12.9%
12.9%
12.9%
12.9%
12.9%
16Total liabilities
1,556
1,891
2,702
2,183
2,340
2,663
2,667
2,486
2,644
2,992
3,360
8%
3,794
4,285
4,839
5,465
6,171
6,969
17ㅤ% Of assets
38.3%
41.9%
47.4%
41%
36.1%
36.8%
31.4%
30%
28.2%
22.9%
24.5%
24.5% A
24.5%
24.5%
24.5%
24.5%
24.5%
24.5%
18Shareholders Equity
2,503
2,619
2,995
3,140
4,148
4,574
5,836
5,807
6,719
10,063
10,338
15.2%
11,675
13,184
14,889
16,815
18,989
21,445
19Net Debt
(121.5)
(107.8)
218.1
(120.3)
(500.3)
(488.3)
(172.5)
(77.7)
(447.2)
(2,345)
(2,233)
33.8%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
660,900
653,400
647,700
640,800
636,600
631,900
631,200
624,200
609,400
599,300
585,800
(1.2)%
578,776
571,837
564,981
558,206
551,514
544,901
21ㅤ% Change
-
(1.1)%
(0.9)%
(1.1)%
(0.7)%
(0.7)%
(0.1)%
(1.1)%
(2.4)%
(1.7)%
(2.3)%
(1.2)%
(1.2)%
(1.2)%
(1.2)%
(1.2)%
(1.2)%
(1.2)%
22ROA
12.2%
12.6%
10.9%
13.6%
16.1%
11.4%
17.7%
18.4%
15%
32%
7.8%
-
11.7%
11.3%
10.9%
10.6%
10.2%
9.3%
23ROE
19.8%
21.7%
20.8%
23%
25.2%
18%
25.8%
26.2%
20.9%
41.5%
10.4%
-
15.4%
14.9%
14.5%
14%
13.5%
12.4%
24Interest coverage
31.3
45.3
43.5
32.7
43.9
58.4
64.9
65
81.1
69.6
-
-
-
-
-
-
-
-
25Dividend Yield
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
26P/E Ratio
34.2
35.1
38.3
44.4
46.3
69.1
53.8
30.3
33
10.6
46.3
-
-
-
-
-
-
-
27Stock price range
21-28
25-40
30-40
37-58
48-82
52-91
79-131
69-128
62-94
60-96
67-87
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
17,020
19,958
23,771
32,043
48,594
56,800
80,749
46,184
46,261
44,248
49,854
11.4%
24,577
26,811
29,269
31,972
34,946
-
29FCF Yield
2.6%
2.4%
3.5%
2.1%
1.9%
1.1%
1.7%
2.1%
1.4%
0.7%
2.7%
0.3%
5.2%
5.3%
5.3%
5.3%
5.3%
-
30Average stock price
24.1
32.6
34.9
47.6
65
71.8
104.7
98.4
78
77.6
77
12.3%
42.5
46.9
51.8
57.3
63.4
-
31 CEO
BZ
Bernard J. Zovighian